STOCK TITAN

Telemark group discloses 5.4% Biodesix (BDSX) position in Schedule 13G filing

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Biodesix, Inc. (BDSX) received a new ownership disclosure from Telemark-related entities reporting a passive stake in its common stock. Telemark Asset Management, LLC, Telemark Fund, LP, and individual investor Colin S. McNay together report beneficial ownership of 427,824 shares of Biodesix common stock, which they state represents approximately 5.4% of the outstanding shares. All reported shares are held with shared power to vote and dispose, and none with sole voting or dispositive power. The filers certify that the shares were not acquired and are not held for the purpose of changing or influencing control of Biodesix, but rather as a passive investment.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Telemark Asset Management, LLC
Signature:/s/ Brian C. Miley
Name/Title:Brian C. Miley, Chief Financial Officer
Date:01/26/2026
Telemark Fund, LP
Signature:By: Telemark Asset Management, LLC, investment adviser, /s/ Brian C. Miley
Name/Title:Brian C. Miley, Chief Financial Officer
Date:01/26/2026
Colin S. McNay
Signature:/s/ Colin S. McNay
Name/Title:Colin S. McNay, President and sole owner of Telemark Asset Management, LLC
Date:01/26/2026
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement

FAQ

What ownership stake in Biodesix, Inc. (BDSX) is reported in this Schedule 13G?

The filing states that the reporting persons collectively may be deemed to beneficially own 427,824 shares of Biodesix, Inc. common stock, representing approximately 5.4% of the outstanding shares.

Who are the reporting persons in this Biodesix (BDSX) Schedule 13G filing?

The Schedule 13G is jointly filed by Telemark Asset Management, LLC, Telemark Fund, LP, and Colin S. McNay, who are referred to collectively as the reporting persons.

Is the Telemark position in Biodesix (BDSX) a passive investment or an attempt to influence control?

The reporting persons certify that the securities were not acquired and are not held for the purpose of changing or influencing the control of Biodesix, and are not held in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.

How is voting and dispositive power over Biodesix (BDSX) shares allocated among the reporting persons?

Each reporting person reports 0 shares with sole voting and dispositive power and 427,824 shares with shared voting and shared dispositive power over Biodesix common stock.

What roles do Telemark Asset Management, LP and Colin S. McNay play in this Biodesix (BDSX) holding?

The filing states that Telemark Asset Management, LLC is the investment adviser to Telemark Fund, LP, and Colin S. McNay is the president and sole owner of Telemark Asset Management, LLC.

Do the reporting persons admit full beneficial ownership of all reported Biodesix (BDSX) shares?

The filing explains that each reporting person declares that neither the filing of the statement nor anything in it should be construed as an admission that such person is the beneficial owner of any securities other than those actually owned by that person, if any.
BIODESIX INC

NASDAQ:BDSX

BDSX Rankings

BDSX Latest News

BDSX Latest SEC Filings

BDSX Stock Data

93.40M
3.68M
54.51%
24.32%
2.1%
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOUISVILLE